Plant-Derived Anti-Inflammatory Compounds: Hopes and Disappointments regarding the Translation of Preclinical Knowledge into Clinical Progress
Top Cited Papers
Open Access
- 29 May 2014
- journal article
- review article
- Published by Hindawi Limited in Mediators of Inflammation
- Vol. 2014, 1-9
- https://doi.org/10.1155/2014/146832
Abstract
Many diseases have been described to be associated with inflammatory processes. The currently available anti-inflammatory drug therapy is often not successful or causes intolerable side effects. Thus, new anti-inflammatory substances are still urgently needed. Plants were the first source of remedies in the history of mankind. Since their chemical characterization in the 19th century, herbal bioactive compounds have fueled drug development. Also, nowadays, new plant-derived agents continuously enrich our drug arsenal (e.g., vincristine, galantamine, and artemisinin). The number of new, pharmacologically active herbal ingredients, in particular that of anti-inflammatory compounds, rises continuously. The major obstacle in this field is the translation of preclinical knowledge into evidence-based clinical progress. Human trials of good quality are often missing or, when available, are frequently not suitable to really prove a therapeutical value. This minireview will summarize the current situation of 6 very prominent plant-derived anti-inflammatory compounds: curcumin, colchicine, resveratrol, capsaicin, epigallocatechin-3-gallate (EGCG), and quercetin. We will highlight their clinical potential and/or pinpoint an overestimation. Moreover, we will sum up the planned trials in order to provide insights into the inflammatory disorders that are hypothesized to be beneficially influenced by the compound.Keywords
This publication has 101 references indexed in Scilit:
- Grape Resveratrol Increases Serum Adiponectin and Downregulates Inflammatory Genes in Peripheral Blood Mononuclear Cells: A Triple-Blind, Placebo-Controlled, One-Year Clinical Trial in Patients with Stable Coronary Artery DiseaseCardiovascular Drugs and Therapy, 2012
- Unravelling the Mystery of Capsaicin: A Tool to Understand and Treat PainPharmacological Reviews, 2012
- Drugs that target dynamic microtubules: A new molecular perspectiveMedicinal Research Reviews, 2011
- Green tea minimally affects biomarkers of inflammation in obese subjects with metabolic syndromeNutrition, 2011
- Chemoprevention of Head and Neck Cancer by Green Tea Extract: EGCG—The Role of EGFR Signaling and “Lipid Raft”Journal of Oncology, 2011
- Regulation of SIRT1 in cellular functions: Role of polyphenolsArchives of Biochemistry and Biophysics, 2010
- (–)-Epigallocatechin Gallate, A Major Constituent of Green Tea, Poisons Human Type II TopoisomerasesChemical Research in Toxicology, 2008
- Raf and MEK Protein Kinases Are Direct Molecular Targets for the Chemopreventive Effect of Quercetin, a Major Flavonol in Red WineCancer Research, 2008
- Cancer Preventive Mechanismsof the Green Tea Polyphenol (-)-Epigallocatechin-3-gallateMolecules, 2007
- Anti-Inflammatory Effects of Flavonoids: Genistein, Kaempferol, Quercetin, and Daidzein Inhibit STAT-1 and NF-B Activations, Whereas Flavone, Isorhamnetin, Naringenin, and Pelargonidin Inhibit only NF-B Activation along with Their Inhibitory Effect on iNOS Expression and NO Production in Activated MacrophagesMediators of Inflammation, 2007